GCH1 and neuroleptic malignant syndrome: Due to the possibility that only NMS may occur in a family member affected by the GCH1 variation, the recommendation to carry out diagnostic studies to investigate the variation in all the individuals of the family under risk is reinforced, especially in those who have no motor symptoms.